Teleflex Incorporated (NYSE:TFX) Stock Position Lifted by Magnetar Financial LLC

Magnetar Financial LLC boosted its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 105.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 421,340 shares of the medical technology company's stock after purchasing an additional 215,961 shares during the period. Teleflex comprises approximately 1.8% of Magnetar Financial LLC's investment portfolio, making the stock its 10th biggest position. Magnetar Financial LLC owned approximately 0.91% of Teleflex worth $74,990,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Avior Wealth Management LLC lifted its position in shares of Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company's stock worth $38,000 after purchasing an additional 101 shares during the period. True Wealth Design LLC boosted its position in Teleflex by 16,600.0% during the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company's stock valued at $41,000 after acquiring an additional 166 shares during the last quarter. IFP Advisors Inc boosted its position in Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after acquiring an additional 217 shares during the last quarter. Banque Cantonale Vaudoise grew its holdings in Teleflex by 184.8% during the 3rd quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company's stock worth $56,000 after acquiring an additional 146 shares during the period. Finally, Exchange Traded Concepts LLC raised its position in shares of Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock worth $61,000 after acquiring an additional 94 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Remove Ads

Teleflex Stock Up 0.0 %

TFX stock traded up $0.06 during mid-day trading on Monday, reaching $141.62. 1,276,248 shares of the company traded hands, compared to its average volume of 548,688. The stock has a market cap of $6.57 billion, a price-to-earnings ratio of 28.16, a P/E/G ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a fifty-two week low of $128.55 and a fifty-two week high of $249.91. The firm's 50 day moving average price is $163.17 and its 200 day moving average price is $193.68. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. As a group, equities research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.96%. The ex-dividend date was Friday, March 7th. Teleflex's dividend payout ratio (DPR) is presently 95.77%.

Analyst Upgrades and Downgrades

TFX has been the subject of several recent analyst reports. Bank of America cut Teleflex from a "neutral" rating to an "underperform" rating and decreased their target price for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. Truist Financial lowered their price objective on shares of Teleflex from $200.00 to $149.00 and set a "hold" rating for the company in a research note on Monday, March 3rd. Morgan Stanley cut their target price on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 5th. Raymond James downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Finally, Citizens Jmp cut shares of Teleflex from an "outperform" rating to a "market perform" rating in a research report on Thursday, February 27th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $182.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.